Collegium Historical Financial Ratios

COLL Stock

USD 29.71 0.15 0.51%

Collegium Pharmaceutical is presently reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0721, PTB Ratio of 5.12 or Days Sales Outstanding of 171 will help investors to properly organize and evaluate Collegium Pharmaceutical financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.

About Collegium Financial Ratios Analysis

Collegium PharmaceuticalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Collegium Pharmaceutical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Collegium financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Collegium Pharmaceutical history.

Collegium Pharmaceutical Financial Ratios Chart

At this time, Collegium Pharmaceutical's PB Ratio is quite stable compared to the past year. Free Cash Flow Per Share is expected to rise to 6.62 this year, although the value of Stock Based Compensation To Revenue will most likely fall to 0.05.

Price To Sales Ratio Dividend Yield Days Sales Outstanding Ev To Sales

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Collegium Pharmaceutical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Collegium Pharmaceutical sales, a figure that is much harder to manipulate than other Collegium Pharmaceutical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Collegium Pharmaceutical dividend as a percentage of Collegium Pharmaceutical stock price. Collegium Pharmaceutical dividend yield is a measure of Collegium Pharmaceutical stock productivity, which can be interpreted as interest rate earned on an Collegium Pharmaceutical investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most ratios from Collegium Pharmaceutical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Collegium Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.At this time, Collegium Pharmaceutical's PB Ratio is quite stable compared to the past year. Free Cash Flow Per Share is expected to rise to 6.62 this year, although the value of Stock Based Compensation To Revenue will most likely fall to 0.05.

	2024	2025 (projected)
Dividend Yield	0.0748	0.0721
Price To Sales Ratio	1.46	1.39

Dividend Yield Price To Sales Ratio

Collegium Pharmaceutical fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		-0.2	0.34	0.99	-0.6	-0.63	-0.81	0.21	0.34	1.0	-0.56	-0.46	-0.71	-0.76	1.0	-0.7	0.94	-0.55	-0.71	-0.55	-0.88	-0.26	-0.62	0.92	0.03	-0.59
Dividend Yield	-0.2		-0.07	-0.14	0.39	0.38	0.43	-0.29	-0.07	-0.2	0.46	0.07	0.0	0.52	-0.2	0.59	-0.25	-0.03	0.08	0.2	0.15	-0.14	0.07	-0.22	0.33	0.19
Ptb Ratio	0.34	-0.07		0.33	-0.32	-0.21	-0.28	0.0	1.0	0.34	-0.16	0.4	-0.16	-0.22	0.34	-0.26	0.31	-0.39	-0.14	-0.11	-0.43	-0.13	-0.09	0.2	-0.02	-0.94
Days Sales Outstanding	0.99	-0.14	0.33		-0.55	-0.58	-0.77	0.17	0.33	0.99	-0.5	-0.46	-0.75	-0.72	0.99	-0.63	0.92	-0.55	-0.72	-0.54	-0.87	-0.3	-0.63	0.91	0.05	-0.57
Book Value Per Share	-0.6	0.39	-0.32	-0.55		0.51	0.65	0.12	-0.32	-0.6	0.47	0.65	0.22	0.62	-0.6	0.64	-0.56	0.81	0.23	0.09	0.7	0.16	0.15	-0.4	0.21	0.48
Free Cash Flow Yield	-0.63	0.38	-0.21	-0.58	0.51		0.8	-0.73	-0.21	-0.63	0.97	0.35	0.54	0.62	-0.63	0.71	-0.8	0.49	0.39	0.43	0.53	-0.45	0.47	-0.6	-0.14	0.42
Operating Cash Flow Per Share	-0.81	0.43	-0.28	-0.77	0.65	0.8		-0.36	-0.28	-0.82	0.8	0.39	0.6	0.87	-0.81	0.77	-0.78	0.57	0.56	0.55	0.68	0.13	0.46	-0.77	0.16	0.53
Capex To Depreciation	0.21	-0.29	0.0	0.17	0.12	-0.73	-0.36		0.0	0.22	-0.75	0.14	-0.22	-0.31	0.21	-0.43	0.47	0.12	-0.19	-0.5	0.03	0.72	-0.36	0.38	0.21	-0.12
Pb Ratio	0.34	-0.07	1.0	0.33	-0.32	-0.21	-0.28	0.0		0.34	-0.16	0.4	-0.16	-0.22	0.34	-0.26	0.31	-0.39	-0.14	-0.11	-0.43	-0.13	-0.09	0.2	-0.02	-0.94
Ev To Sales	1.0	-0.2	0.34	0.99	-0.6	-0.63	-0.82	0.22	0.34		-0.56	-0.46	-0.72	-0.77	1.0	-0.7	0.94	-0.55	-0.72	-0.55	-0.88	-0.27	-0.62	0.92	0.03	-0.59
Free Cash Flow Per Share	-0.56	0.46	-0.16	-0.5	0.47	0.97	0.8	-0.75	-0.16	-0.56		0.28	0.42	0.63	-0.56	0.72	-0.74	0.43	0.36	0.39	0.46	-0.49	0.44	-0.54	0.0	0.37
Roic	-0.46	0.07	0.4	-0.46	0.65	0.35	0.39	0.14	0.4	-0.46	0.28		0.33	0.36	-0.46	0.32	-0.44	0.55	0.26	0.02	0.5	0.11	0.23	-0.34	-0.02	-0.2
Inventory Turnover	-0.71	0.0	-0.16	-0.75	0.22	0.54	0.6	-0.22	-0.16	-0.72	0.42	0.33		0.46	-0.72	0.38	-0.67	0.37	0.79	0.41	0.61	0.18	0.78	-0.65	-0.33	0.39
Net Income Per Share	-0.76	0.52	-0.22	-0.72	0.62	0.62	0.87	-0.31	-0.22	-0.77	0.63	0.36	0.46		-0.76	0.75	-0.7	0.42	0.6	0.63	0.57	0.23	0.49	-0.78	0.38	0.5
Days Of Inventory On Hand	1.0	-0.2	0.34	0.99	-0.6	-0.63	-0.81	0.21	0.34	1.0	-0.56	-0.46	-0.72	-0.76		-0.7	0.94	-0.55	-0.72	-0.55	-0.88	-0.27	-0.63	0.92	0.03	-0.59
Payables Turnover	-0.7	0.59	-0.26	-0.63	0.64	0.71	0.77	-0.43	-0.26	-0.7	0.72	0.32	0.38	0.75	-0.7		-0.74	0.35	0.58	0.42	0.61	-0.06	0.55	-0.64	-0.08	0.47
Capex To Revenue	0.94	-0.25	0.31	0.92	-0.56	-0.8	-0.78	0.47	0.31	0.94	-0.74	-0.44	-0.67	-0.7	0.94	-0.74		-0.52	-0.65	-0.51	-0.83	0.08	-0.64	0.86	0.11	-0.54
Cash Per Share	-0.55	-0.03	-0.39	-0.55	0.81	0.49	0.57	0.12	-0.39	-0.55	0.43	0.55	0.37	0.42	-0.55	0.35	-0.52		0.27	0.04	0.67	0.12	0.23	-0.34	0.16	0.53
Pocfratio	-0.71	0.08	-0.14	-0.72	0.23	0.39	0.56	-0.19	-0.14	-0.72	0.36	0.26	0.79	0.6	-0.72	0.58	-0.65	0.27		0.34	0.64	0.25	0.96	-0.63	-0.12	0.38
Interest Coverage	-0.55	0.2	-0.11	-0.54	0.09	0.43	0.55	-0.5	-0.11	-0.55	0.39	0.02	0.41	0.63	-0.55	0.42	-0.51	0.04	0.34		0.1	0.17	0.29	-0.83	0.0	0.32
Payout Ratio	-0.88	0.15	-0.43	-0.87	0.7	0.53	0.68	0.03	-0.43	-0.88	0.46	0.5	0.61	0.57	-0.88	0.61	-0.83	0.67	0.64	0.1		0.22	0.56	-0.62	-0.03	0.6
Capex To Operating Cash Flow	-0.26	-0.14	-0.13	-0.3	0.16	-0.45	0.13	0.72	-0.13	-0.27	-0.49	0.11	0.18	0.23	-0.27	-0.06	0.08	0.12	0.25	0.17	0.22		-0.01	-0.25	0.24	0.18
Pfcf Ratio	-0.62	0.07	-0.09	-0.63	0.15	0.47	0.46	-0.36	-0.09	-0.62	0.44	0.23	0.78	0.49	-0.63	0.55	-0.64	0.23	0.96	0.29	0.56	-0.01		-0.55	-0.22	0.32
Days Payables Outstanding	0.92	-0.22	0.2	0.91	-0.4	-0.6	-0.77	0.38	0.2	0.92	-0.54	-0.34	-0.65	-0.78	0.92	-0.64	0.86	-0.34	-0.63	-0.83	-0.62	-0.25	-0.55		0.02	-0.47
Income Quality	0.03	0.33	-0.02	0.05	0.21	-0.14	0.16	0.21	-0.02	0.03	0.0	-0.02	-0.33	0.38	0.03	-0.08	0.11	0.16	-0.12	0.0	-0.03	0.24	-0.22	0.02		0.08
Roe	-0.59	0.19	-0.94	-0.57	0.48	0.42	0.53	-0.12	-0.94	-0.59	0.37	-0.2	0.39	0.5	-0.59	0.47	-0.54	0.53	0.38	0.32	0.6	0.18	0.32	-0.47	0.08

Click cells to compare fundamentals

Collegium Pharmaceutical Account Relationship Matchups

Collegium Pharmaceutical fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	2.22	2.36	1.69	1.83	1.46	1.39
Ptb Ratio	3.7	3.22	4.03	5.31	4.04	5.12
Days Sales Outstanding	98.1	139.54	144.07	115.61	132.1	171.42
Book Value Per Share	5.41	5.81	5.76	5.79	7.09	7.45
Free Cash Flow Yield	0.26	0.031	(0.41)	0.16	0.22	0.23
Operating Cash Flow Per Share	2.73	2.96	3.67	8.14	6.35	6.67
Stock Based Compensation To Revenue	0.0707	0.0876	0.0493	0.0479	0.0513	0.0487
Capex To Depreciation	6.07	0.0282	0.0117	0.003089	0.0101	0.009612
Pb Ratio	3.7	3.22	4.03	5.31	4.04	5.12
Ev To Sales	2.52	2.62	3.2	2.6	2.71	2.58
Free Cash Flow Per Share	(8.13)	2.91	3.62	8.13	6.3	6.62
Roic	(0.009835)	1.93	(0.0848)	0.12	0.0978	0.1
Inventory Turnover	8.34	7.26	5.47	7.44	7.15	6.98
Net Income Per Share	0.78	2.05	(0.74)	1.43	2.14	2.25
Days Of Inventory On Hand	43.78	50.29	66.71	49.05	51.08	48.52
Payables Turnover	13.0	30.14	72.82	27.68	64.59	67.82
Research And Ddevelopement To Revenue	0.0348	0.0315	0.0341	0.008585	0.009873	0.009379
Capex To Revenue	1.21	0.007021	0.003496	8.13E-4	0.002616	0.002485
Cash Per Share	5.06	5.34	5.13	9.2	5.04	3.86
Pocfratio	7.34	6.3	6.32	3.78	4.51	4.74
Interest Coverage	(0.18)	(2.22)	(1.65)	2.0	2.3	2.41
Capex To Operating Cash Flow	3.98	0.0188	0.0131	0.001678	0.008059	0.007656
Pfcf Ratio	(2.46)	6.42	6.4	3.79	4.55	4.77
Days Payables Outstanding	28.08	12.11	5.01	13.19	5.65	5.37
Income Quality	3.51	1.45	(4.97)	5.71	2.96	3.11
Roe	0.14	0.35	(0.13)	0.25	0.3	0.32
Ev To Operating Cash Flow	8.32	7.0	11.95	5.36	8.36	8.78
Pe Ratio	25.76	9.13	(31.39)	21.57	13.36	14.03
Return On Tangible Assets	0.0869	0.17	(0.0529)	0.0819	0.11	0.12
Ev To Free Cash Flow	(2.79)	7.13	12.1	5.37	8.43	8.85
Earnings Yield	0.0388	0.11	(0.0319)	0.0464	0.0748	0.0786
Intangibles To Total Assets	0.52	0.39	0.6	0.49	0.63	0.67
Net Debt To E B I T D A	0.78	0.84	4.14	1.41	4.64	2.75
Current Ratio	1.45	1.37	1.55	1.17	0.95	0.9
Tangible Book Value Per Share	(4.36)	(1.88)	(14.97)	(10.67)	(25.56)	(24.28)
Receivables Turnover	3.72	2.62	2.53	3.16	2.76	2.32
Shareholders Equity Per Share	5.41	5.81	5.76	5.79	7.09	7.45
Debt To Equity	1.43	1.28	4.48	3.45	3.75	3.94

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Collegium Pharmaceutical is a strong investment it is important to analyze Collegium Pharmaceutical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Collegium Pharmaceutical's future performance. For an informed investment choice regarding Collegium Stock, refer to the following important reports:

How To Invest In Collegium

Details

Is Collegium Stock a good investment?

Details

What is Collegium Pharmaceutical's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Collegium Historical Financial Ratios

About Collegium Financial Ratios Analysis

Collegium Pharmaceutical Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ev To Sales

Collegium Pharmaceutical fundamentals Correlations

Collegium Pharmaceutical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Collegium Pharmaceutical fundamentals Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Days Of Inventory On Hand	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Days Of Inventory On Hand	+ 1.0	Ev To Sales
Days Sales Outstanding	+ 0.99	Price To Sales Ratio
Ev To Sales	+ 0.99	Days Sales Outstanding

Roe	- 0.94	Pb Ratio
Roe	- 0.94	Ptb Ratio
Payout Ratio	- 0.88	Days Of Inventory On Hand
Payout Ratio	- 0.88	Ev To Sales
Payout Ratio	- 0.88	Price To Sales Ratio
Payout Ratio	- 0.87	Days Sales Outstanding